Healthy Volunteers Clinical Trial
Official title:
VISUALIZATION OF THE MICROCIRCULATION IN WEIGHTLESSNESS
During weightlessness, the cardiovascular system is subject to rapid changes which has been
demonstrated in studies of short term (Space Shuttle) and long term missions to Skylab, MIR,
and the International Space Station (Nicogossian et al., 1989; Blomquist, 1994; Platts et
al., 2014). There is also evidence for changes in the blood vessel structure, the metabolism
and the responses to vasodilator and constrictor substances that might have long-term health
consequences resembling the effects of aging on the cardiovascular system (Hughson and
Shoemaker, 2004). Cardiovascular adaptations cause an increased incidence of postflight
orthostatic intolerance (fainting), decreased cardiac output and reduced exercise capacity.
Besides these postflight effects, weightlessness could also have harmful consequences during
the flight. For example, it has been shown that cardiac arrhythmia may occur during space
missions, even in healthy individuals (Convertino, 2009).
To understand the cardiovascular reactions of the human body to changing conditions of
gravity is thus an important aim of space science.
While non-invasive imaging of microcirculation is a very promising tool to evaluate
cardiovascular condition, knowledge on the involvement of the microcirculation in
cardiovascular alterations induced by weightlessness is very limited and further research in
this field seems promising. Before using a non-invasive technique for imaging the
microcirculation during space flights, it has to be evaluated on earth.
Different proven simulation models exist for investigating the effects of weightlessness on
the human body under terrestrial conditions: head down bed rest, dry and wet immersion, and
parabolic flights. Among these models, only parabolic flight recreates a real state of
weightlessness (see the participant document of information for a description of parabolic
flights). Cardiovascular studies have often been performed during parabolic flights. Within
the limitations inherent to the method (short duration of weightlessness - about 21 s -
following and followed by hypergravity 20 s periods at 1.8g), some remarkable results have
been published over the years.
The aim of our research approach is to test feasibility of the in vivo evaluation of the
microcirculation in parabolic flight in order to be able to better describe cardiovascular
response mechanisms under these conditions. In this context, we expect alterations in the
microcirculatory flow during the weightlessness period of parabolic flight.
Our approach might help develop a diagnostic tool to more easily identify
weightlessness-induced cardiovascular diseases and improve strategies for adapting astronauts
to weightlessness prior to the space mission.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |